Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lilly Q Yue

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Biopharmaceutical Statistics|January 16, 2007
Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studiesLilly Q Yue
Journal of Biopharmaceutical Statistics|October 19, 2012
Regulatory considerations in the design of comparative observational studies using propensity scoresLilly Q Yue
Journal of Biopharmaceutical Statistics|September 16, 2015
Statistical innovations in the medical device world sparked by the FDAGregory Campbell, Lilly Q Yue
Journal of Biopharmaceutical Statistics|July 12, 2014
Guest editors' note: Special issue associated with the 2013 ASA Biopharmaceutical FDA/Industry Statistics WorkshopBruce Binkowitz, Lilly Q Yue
Journal of Biopharmaceutical Statistics|August 23, 2016
A conversation with Dr. Greg CampbellAiyi Liu, Lilly Q Yue
Journal of Biopharmaceutical Statistics|December 29, 2007
Statistical and regulatory issues in nonrandomized medical device clinical studiesHeng Li, Lilly Q Yue
Pharmaceutical Statistics|February 16, 2023
Propensity score-based methods for causal inference and external data leveraging in regulatory settings: From basic ideas to implementationHeng Li, Lilly Q Yue
Journal of Biopharmaceutical Statistics|January 22, 2013
Regulatory issues of propensity score methodology application to drug and device safety studiesMark S Levenson, Lilly Q Yue
Journal of Biopharmaceutical Statistics|July 2, 2019
Good statistical practice in utilizing real-world data in a comparative study for premarket evaluation of medical devicesNelson Lu, Yunling Xu, Lilly Q Yue
Journal of Biopharmaceutical Statistics|July 12, 2014
Designing premarket observational comparative studies using existing data as controls: challenges and opportunitiesLilly Q Yue, Nelson Lu, Yunling Xu
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Biopharmaceutical Statistics|January 16, 2007
Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studiesLilly Q Yue
Journal of Biopharmaceutical Statistics|October 19, 2012
Regulatory considerations in the design of comparative observational studies using propensity scoresLilly Q Yue
Journal of Biopharmaceutical Statistics|September 16, 2015
Statistical innovations in the medical device world sparked by the FDAGregory Campbell, Lilly Q Yue
Journal of Biopharmaceutical Statistics|July 12, 2014
Guest editors' note: Special issue associated with the 2013 ASA Biopharmaceutical FDA/Industry Statistics WorkshopBruce Binkowitz, Lilly Q Yue
Journal of Biopharmaceutical Statistics|August 23, 2016
A conversation with Dr. Greg CampbellAiyi Liu, Lilly Q Yue
Journal of Biopharmaceutical Statistics|December 29, 2007
Statistical and regulatory issues in nonrandomized medical device clinical studiesHeng Li, Lilly Q Yue
Pharmaceutical Statistics|February 16, 2023
Propensity score-based methods for causal inference and external data leveraging in regulatory settings: From basic ideas to implementationHeng Li, Lilly Q Yue
Journal of Biopharmaceutical Statistics|January 22, 2013
Regulatory issues of propensity score methodology application to drug and device safety studiesMark S Levenson, Lilly Q Yue
Journal of Biopharmaceutical Statistics|July 2, 2019
Good statistical practice in utilizing real-world data in a comparative study for premarket evaluation of medical devicesNelson Lu, Yunling Xu, Lilly Q Yue
Journal of Biopharmaceutical Statistics|July 12, 2014
Designing premarket observational comparative studies using existing data as controls: challenges and opportunitiesLilly Q Yue, Nelson Lu, Yunling Xu
Pageof 4